DE3852140D1 - Produktion von Proteinen in aktiven Formen. - Google Patents
Produktion von Proteinen in aktiven Formen.Info
- Publication number
- DE3852140D1 DE3852140D1 DE3852140T DE3852140T DE3852140D1 DE 3852140 D1 DE3852140 D1 DE 3852140D1 DE 3852140 T DE3852140 T DE 3852140T DE 3852140 T DE3852140 T DE 3852140T DE 3852140 D1 DE3852140 D1 DE 3852140D1
- Authority
- DE
- Germany
- Prior art keywords
- protein
- proteins
- production
- rupturing
- active forms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPI046287 | 1987-02-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3852140D1 true DE3852140D1 (de) | 1995-01-05 |
DE3852140T2 DE3852140T2 (de) | 1995-04-06 |
Family
ID=3772028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3852140T Expired - Fee Related DE3852140T2 (de) | 1987-02-20 | 1988-02-16 | Produktion von Proteinen in aktiven Formen. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4966963A (de) |
EP (1) | EP0279619B1 (de) |
JP (1) | JPS63264598A (de) |
AT (1) | ATE114319T1 (de) |
AU (1) | AU612133B2 (de) |
CA (1) | CA1326106C (de) |
DE (1) | DE3852140T2 (de) |
ES (1) | ES2065906T3 (de) |
NZ (1) | NZ223559A (de) |
ZA (1) | ZA881067B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU612133B2 (en) * | 1987-02-20 | 1991-07-04 | Natinco Nv | Production of proteins in active forms |
AU609824B2 (en) * | 1987-06-15 | 1991-05-09 | Southern Cross Biotech Pty Ltd. | Production of proteins in active forms |
DE3887521T2 (de) * | 1987-06-26 | 1994-08-18 | Commw Scient Ind Res Org | Durch virusneutralisierende und schützende monokonale antikörper erkanntes ibdv vp2 epitop. |
US5136027A (en) * | 1989-05-02 | 1992-08-04 | Abbott Laboratories | Method for renaturing proteins in the presence of alkyl sulfate detergents |
US5101018A (en) * | 1989-06-12 | 1992-03-31 | International Minerals & Chemical Corp. | Method for recovering recombinant proteins |
EP0432419B1 (de) * | 1989-12-05 | 1994-10-19 | American Cyanamid Company | Methode zur Auflösung und Naturation von Somatotropin unter Verwendung von einer niedrigen Harnstoffkonzentration |
DE69129747T2 (de) * | 1990-09-05 | 1998-11-12 | Southern Cross Biotech Pty Ltd | In lösung bringen von proteinen in aktiver form |
US6566098B1 (en) * | 1990-09-14 | 2003-05-20 | The United States Of America As Represented By The Department Of Health And Human Services | DNA encoding truncated hepatocyte growth factor variants |
GB2281558B (en) * | 1993-09-07 | 1997-02-19 | Joseph Matthew Gaugas | Supplying sulphur to plants |
US5861372A (en) * | 1996-02-22 | 1999-01-19 | The Children's Medical Center Corporation | Aggregate angiostatin and method of use |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
US5840838A (en) * | 1996-02-29 | 1998-11-24 | University Of Kentucky Research Foundation | Process for enhancing the activity of amyloid β peptides |
US20030190307A1 (en) * | 1996-12-24 | 2003-10-09 | Biogen, Inc. | Stable liquid interferon formulations |
US6566583B1 (en) | 1997-06-04 | 2003-05-20 | Daniel Facciotti | Schizochytrium PKS genes |
EP2158923B1 (de) | 1998-08-06 | 2013-02-27 | Mountain View Pharmaceuticals, Inc. | Peg-uricase Konjugate und Verwendung davon |
US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
ES2538357T3 (es) | 2005-04-11 | 2015-06-19 | Crealta Pharmaceuticals Llc | Formas variantes de urato oxidasa y uso de las mismas |
US20080159976A1 (en) * | 2005-04-11 | 2008-07-03 | Jacob Hartman | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
JP2008535499A (ja) * | 2005-04-11 | 2008-09-04 | サビエント ファーマセウティカルズ インク. | 変異型尿酸オキシダーゼおよびその利用 |
US20090081122A1 (en) * | 2005-05-23 | 2009-03-26 | Universite De Geneve | Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant |
KR101288027B1 (ko) | 2006-04-12 | 2013-07-22 | 새비언트 파마수티컬즈 인크. | 양이온 계면활성제를 이용한 단백질 정제 방법 |
WO2010057097A1 (en) | 2008-11-17 | 2010-05-20 | Cornell University | A system useful for reporting protein-protein interactions in the bacterial periplasm |
NZ597089A (en) | 2009-06-25 | 2014-05-30 | Savient Pharmaceuticals Inc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2829089A1 (de) * | 1977-07-13 | 1979-02-01 | Sandoz Ag | Subunit-vakzine |
US4462940A (en) * | 1982-09-23 | 1984-07-31 | Cetus Corporation | Process for the recovery of human β-interferon-like polypeptides |
GR79124B (de) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
ES8800957A1 (es) * | 1985-02-22 | 1987-12-01 | Monsanto Co | Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina |
US4731440A (en) * | 1985-02-22 | 1988-03-15 | Monsanto Company | Method of somatotropin solubilization using dimethylsulfone and naturation |
US4766224A (en) * | 1985-08-19 | 1988-08-23 | International Minerals & Chemical Corp. | Purification and activation of proteins from insoluble inclusion bodies |
AU597924B2 (en) * | 1985-12-11 | 1990-06-14 | Natinco Nv | Solubilization of protein aggregates |
AU612133B2 (en) * | 1987-02-20 | 1991-07-04 | Natinco Nv | Production of proteins in active forms |
AU607988B2 (en) * | 1987-04-21 | 1991-03-21 | Southern Cross Biotech Pty Ltd. | Production of proteins in active forms |
AU1763188A (en) * | 1987-06-15 | 1988-12-15 | Bunge (Australia) Pty Ltd | Recovery of proteins in active form |
-
1988
- 1988-02-08 AU AU11412/88A patent/AU612133B2/en not_active Ceased
- 1988-02-11 US US07/154,938 patent/US4966963A/en not_active Expired - Lifetime
- 1988-02-16 DE DE3852140T patent/DE3852140T2/de not_active Expired - Fee Related
- 1988-02-16 AT AT88301257T patent/ATE114319T1/de not_active IP Right Cessation
- 1988-02-16 ZA ZA881067A patent/ZA881067B/xx unknown
- 1988-02-16 CA CA000558944A patent/CA1326106C/en not_active Expired - Fee Related
- 1988-02-16 ES ES88301257T patent/ES2065906T3/es not_active Expired - Lifetime
- 1988-02-16 EP EP88301257A patent/EP0279619B1/de not_active Expired - Lifetime
- 1988-02-18 NZ NZ223559A patent/NZ223559A/xx unknown
- 1988-02-19 JP JP63037341A patent/JPS63264598A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US4966963A (en) | 1990-10-30 |
CA1326106C (en) | 1994-01-11 |
ZA881067B (en) | 1988-08-11 |
EP0279619B1 (de) | 1994-11-23 |
NZ223559A (en) | 1989-09-27 |
AU1141288A (en) | 1988-08-25 |
EP0279619A2 (de) | 1988-08-24 |
ATE114319T1 (de) | 1994-12-15 |
DE3852140T2 (de) | 1995-04-06 |
JPS63264598A (ja) | 1988-11-01 |
AU612133B2 (en) | 1991-07-04 |
ES2065906T3 (es) | 1995-03-01 |
EP0279619A3 (en) | 1990-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3852140D1 (de) | Produktion von Proteinen in aktiven Formen. | |
PL274485A1 (en) | Method of obtaining stable preparations of human proteins | |
FI914241A0 (fi) | Vacciner foer icke-typade haemo philus influenzae-bakterier. | |
ATE114156T1 (de) | Herstellung von proteinen in aktiver form. | |
SE8602405D0 (sv) | Ny formulering | |
ATE68826T1 (de) | Verfahren zur herstellung von reifem, menschlichem serum-albumin. | |
ATE82857T1 (de) | Interleukin-2-zusammensetzungen. | |
HK46896A (en) | Process for the renaturation of proteins | |
DE69129747D1 (de) | In lösung bringen von proteinen in aktiver form | |
MY103362A (en) | Production of proteins in active forms | |
EP0315118A3 (de) | Endothelin kodierendes DNA und dessen Verwendung | |
GR860329B (en) | Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof | |
NZ235297A (en) | Aqueous solution containing a protein and anionic polymer or salt and method of increasing the protein concentration of an aqueous solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: NANTINCO, NV, WILLENSTED, CURACAO, AN |
|
8339 | Ceased/non-payment of the annual fee |